Invivyd (IVVD) EBITDA (2021 - 2025)

Invivyd has reported EBITDA for 5 years, with the latest figure at -$11.1 million in Q4 2025.

• For the quarter ending Q4 2025, EBITDA rose 39.93% year-over-year to -$11.1 million; the trailing twelve-month figure through Dec 2025 stood at -$52.5 million (up 69.09% YoY), and the FY2025 full-year result was -$52.5 million, up 69.09% from the prior year.
• EBITDA for Q4 2025 stood at -$11.1 million, down from -$10.5 million in the prior quarter.
• The five-year high for EBITDA was -$10.5 million in Q3 2025, with the low at -$100.7 million in Q1 2022.
• Historically, EBITDA has averaged -$44.5 million across 5 years, with a median of -$44.8 million in 2021.
• Annual changes were most pronounced in 2022 — EBITDA slumped 160.1% — and 2025, when it surged 82.76%.
• Invivyd's EBITDA stood at -$83.1 million in 2021, then surged by 45.95% to -$44.9 million in 2022, then sank by 64.09% to -$73.7 million in 2023, then surged by 74.98% to -$18.4 million in 2024, then surged by 39.93% to -$11.1 million in 2025.
• The last three EBITDA figures came in at -$11.1 million (Q4 2025), -$10.5 million (Q3 2025), and -$14.7 million (Q2 2025), per Business Quant data.